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A Simplified Technique of Percutaneous
Hepatic Artery Port-Catheter Insertion for
the Treatment of Advanced
Hepatocellular Carcinoma with Portal
Vein Invasion
Objective: We assessed the outcomes of a simplified technique for the percu-
taneous placement of a hepatic artery port-catheter system for chemotherapy
infusion in advanced hepatocellular carcinoma with portal vein invasion.
Materials and Methods: From February 2003 to February 2008, percutaneous
hepatic artery port-catheter insertion was performed in 122 patients who had
hepatocellular carcinoma with portal vein invasion. The arterial access route was
the common femoral artery. The tip of the catheter was wedged into the right gas-
troepiploic artery without an additional fixation device. A side hole was positioned
at the distal common hepatic artery to allow the delivery of chemotherapeutic
agents into the hepatic arteries. Coil embolization was performed only to redistrib-
ute to the hepatic arteries or to prevent the inadvertent delivery of chemothera-
peutic agents into extrahepatic arteries. The port chamber was created at either
the supra-inguinal or infra-inguinal region.
Results: Technical success was achieved in all patients. Proper positioning of
the side hole was checked before each scheduled chemotherapy session by port
angiography. Catheter-related complications occurred in 19 patients (16%).
Revision was achieved in 15 of 18 patients (83%). 
Conclusion: This simplified method demonstrates excellent technical feasibili-
ty, an acceptable range of complications, and is hence recommended for the
management of advanced hepatocellular carcinoma with portal vein thrombosis.
epatic arterial infusion chemotherapy is an alternative treatment for
patients with unresectable liver tumors (1, 2). Repeated hepatic arterial
delivery of chemotherapeutic agents to the liver by a percutaneously
implanted port-catheter system has been widely used to treat advanced unresectable
liver cancer (3, 4). Instead of laparotomy, percutaneous implantation of port-catheter
systems for intra-arterial use in various target organs, particularly in regional
chemotherapy of the liver, has been successfully performed by interventional radiolo-
gists under local anesthesia (5-11). Among the various interventional techniques, the
classic fixed-catheter-tip method has some advantages, such as increased stability of
the indwelling catheter and a decreased rate of hepatic arterial occlusion (12, 13).
However, this method, which uses microcoils alone or n-butyl cyanoacrylate, is a
lengthy procedure, and removal of the implanted port-catheter system can be difficult.
At our institute, a new, simplified fixed-catheter-tip method without microcoils or n-
butyl cyanoacrylate was adapted for the indwelling catheter in hepatic arterial infusion
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Hchemotherapy. The purpose of this study was to assess the
patency and complications of the new fixed-catheter-tip
method.
MATERIALS AND METHODS
Patients
Between February 2003 and February 2008, a port-
catheter system was implanted percutaneously by
interventional radiologists in 122 consecutive patients who
had unresectable hepatocellular carcinoma (HCC) with
portal vein invasion. Indications for hepatic arterial
infusion chemotherapy were as follows: 1) unresectable
liver tumors (n = 103), 2) hepatic lobectomy status with
recurrent HCC combined portal vein invasion (n = 7), 3)
size reduction of HCC before surgery (n = 1), 4) other
concomitant malignancy (n = 1), 5) refusal of both surgery
and repeated transarterial chemoembolization (n = 9), and
6) unsuitable general condition for surgery (n = 1). The age
of the patients ranged from 29 to 76 years (54±10 years,
mean ± standard deviation [SD]). Clinical characteristics
of the 122 patients are shown in Table 1. 
Before the procedure, written informed consent was
obtained from all the patients. Institutional review board
approval was also obtained for this retrospective study.
Techniques
All procedures were performed percutaneously in
angiographic suites by interventional radiologists. Before
catheter placement, all patients underwent transfemoral
angiography for arterial road mapping and, if necessary,
arterial redistribution to convert multiple hepatic arteries
into a single arterial supply (14, 15). If necessary,
extrahepatic arterial branches arising from the hepatic
artery were occluded to prevent inadvertent drug delivery
using stainless steel microcoils (3-6 mm; Tornado
embolization coils; Cook Medical Inc., Bloomington, IN).
Catheter placement was performed under local anesthesia
immediately after angiography. The right or left common
femoral artery was chosen as the access route. The catheter
tip was placed in the right gastroepiploic artery without a
distal fixation device such as a coil or n-butyl cyanoacry-
late (Fig. 1). The procedure was performed as follows:
1. A 5-Fr catheter (RH-R; Cook Medical Inc.,
Bloomington, IN) was inserted under local anesthesia
from the common femoral artery and was advanced to
the superior mesenteric artery, where the angiography
was performed (Fig. 2A). The catheter tip was reposi-
tioned in the common hepatic artery via the celiac
trunk, and a common hepatic artery arteriography was
performed (Fig. 2B). For accurate anatomical evalua-
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Table 1. Clinical Characteristics of 122 Patients with
Advanced Hepatocellular Carcinoma with Portal
Vein Thrombosis Who Underwent Percutaneous
Hepatic Artery Port-Catheter Insertion
Characteristics Patients (n = 122)
Age (years) 54 ± 10
Gender
Women 020 (16%)
Men 102 (84%)
Degree of hepatic impairment
Child-Pugh A 112 (92%)
Child-Pugh B 10 (8%)
Child-Pugh C 000 (0%)0
Stage*, portal vein invasion
II 11 (9%)
unilateral segmental 11 (9%)
IIIA  030 (25%)
unilateral segmental 013 (11%)
bilateral segmental 03 (3%)
unilateral main 11 (9%)
bilateral main 01 (1%)
extrahepatic extension 02 (2%)
IIIB  08 (7%)
unilateral segmental 02 (2%)
bilateral segmental 00 (2%)
unilateral main 03 (3%)
bilateral main 00 (2%)
extrahepatic extension 03 (3%)
IIIC  02 (2%)
unilateral segmental 01 (1%)
bilateral segmental 01 (1%)
unilateral main 00 (2%)
bilateral main 00 (2%)
extrahepatic extension 00 (2%)
IVA  054 (44%)
unilateral segmental 014 (12%)
bilateral segmental 03 (3%)
unilateral main 019 (16%)
bilateral main 04 (3%)
extrahepatic extension 014 (12%)
IVB  017 (14%)
unilateral segmental 04 (3%)
bilateral segmental 00 (2%)
unilateral main 07 (6%)
bilateral main 02 (2%)
extrahepatic extension 04 (3%)
Underlying liver disease
HBV 091 (75%)
HCV 08 (7%)
Non-HBV and non-HCV 012 (10%)
HBV and alcoholic cirrhosis 04 (3%)
Alcoholic cirrhosis 07 (6%)
Note.─ Data are presented as mean ± standard deviation or number 
(percent).
* = American Joint Committee on Cancer (AJCC) in 2010 (29).
HBV = hepatitis B virus, HCV = hepatitis C virustion, 5 μ g of Lipo-PGE1 (lipidencapsulated preparation
of prostaglandin E1, Eglandin; WelFide Korea Co.,
Ltd., Seoul, Korea) was administered directly into the
superior mesenteric artery immediately before angiog-
raphy.
2. A microcatheter was inserted coaxially, and coil
embolization was performed to prevent extrahepatic
drug distribution or arterial redistribution.
3. The catheter tip location was determined by celiac
arteriography, and was placed at the right gastroepi-
ploic artery about 3-5 cm from the ostium of the right
gastroepiploic artery.
4. After determining the catheter tip location, a side hole
was made in the catheter using small scissors, and was
adjusted at the distal common hepatic artery. The
distance between the side hole and the distal end of
the indwelling catheter was determined from the
results of the celiac arteriography. Before implantation
of the port-catheter system, a test injection using
sterile saline was performed through the catheter to
confirm the absence of flow through the distal end of
the catheter. The port chamber was created after
povidone-iodine soaking of the low abdominal wall or
upper anterior thigh, and then subcutaneous tunneling
was performed. 
5. Using the catheter-exchange method, an indwelling
catheter with one side hole (5-Fr polyurethane
catheter [Healthport LP set; Baxter Healthcare Co.,
Deerfield, IL] or 5.8-Fr polyurethane catheter
[PolyFlow; Deltec Inc., St. Paul, MN]) was inserted via
the right or left common femoral artery. The tip of the
catheter was wedged into the right gastroepiploic
artery. No additional distal-tip-fixation material, such
as a coil or n-butyl cyanoacrylate, was used. The distal
tip of the catheter was not occluded. The side hole was
placed into the distal common hepatic artery, and its
location and patency were confirmed by a test
injection of contrast media (Fig. 2C).
6. The proximal segment of the indwelling catheter was
embedded in the subcutaneous tunnel, and the
proximal end of the catheter was cut and connected to
a port (Healthport LP [Baxter] or Port-A-Cath [Deltec
Inc., St. Paul, MN]), which was implanted in the
subcutaneous space. Port-catheter angiography was
performed to confirm the location of the side hole.
The subcutaneous tissue was flushed with antibiotic
solution and sutured aseptically (the skin was closed
with staples) and 2000 IU of heparin was inserted into
the port. To prevent thrombosis of the port-catheter
system, the port was flushed with saline and heparin
(2000 IU) after each administration of chemothera-
peutic drugs.
Follow-Up
Before chemotherapy, all patients underwent digital
subtraction angiography after infusion of the contrast
material via the port to confirm the patency of the hepatic
artery and indwelling catheter (Fig. 2D). Follow-up
intervals depended on the clinical characteristics of the
patients.
Port-catheter system removal was performed by pulling
gently on the catheter under fluoroscopic guidance in
angiographic suites by radiologists, and under local
anesthesia, at the physician’s request. The duration of this
procedure was only a few minutes.
RESULTS
The port-catheter systems were implanted successfully,
and hepatic arterial infusion chemotherapy was initiated in
all 122 patients, with a mean follow-up duration of 145±
133.6 days (mean ± SD; range, 1-861 days; median, 101
days). The number of arterial infusion chemotherapy
sessions using the port-catheter system was 3.9 ± 2.4
(mean ± SD; range, 1-15; median, 3). 
In 115 of 122 patients, the right common femoral artery
was chosen as the puncture site for implantation of the
port-catheter system. For the other seven patients, the left
common femoral artery was chosen as the puncture site,
because of right iliac artery occlusion (n = 1), severe
fibrosis at the right inguinal region caused by previous
repeated transarterial chemoembolization (n = 1), or the
patient’s preference for the chamber site of the port-
catheter system (n = 5). In 30 of 122 patients (25%, n =
32), coil embolization was performed to prevent extrahep-
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Fig. 1. Illustration of our simplified fixed-catheter-tip method with
no additional fixation material.atic drug distribution or arterial redistribution. The distrib-
ution of the embolized arteries was as follows: right gastric
artery (n = 15), superior pancreaticoduodenal artery (n =
7), left gastric artery (n = 6), replaced left hepatic artery (n
= 2), and replaced right hepatic artery (n = 2).
In total, 30 cases with complications were related to the
port-catheter system (n = 19, 16%) (Table 2), and to
chemotherapy (i.e., acute gastroduodenal mucosal lesions;
n = 11, 9%). On scheduled digital subtraction angiogra-
phies that were performed before chemotherapy, 106 of
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Fig. 2. Hepatocellular carcinoma treatment using implantable port-catheter system with our simplified fixed-catheter-tip method. 
72-year-old man with advanced hepatocellular carcinoma and left portal vein invasion. Transarterial chemoembolization was performed
1-week before procedure.
A. Superior mesenteric artery angiography was performed using 5-Fr catheter with nonvisualization of left portal vein (arrows) because
of tumor invasion.
B. Celiac angiography revealed extensive tumor staining (black arrows) involving left hepatic lobe. Previously treated region of hepato-
cellular carcinoma involving left lateral segment was not stained (white arrows).
C. 5-Fr indwelling catheter with side hole was inserted in right common femoral artery. Tip of catheter was wedged into proximal portion
of right gastroepiploic artery. No additional distal tip-fixation material, such as coil or n-butyl cyanoacrylate, was used. Location of side
hole was confirmed by test injection of contrast media, and proper hepatic artery (arrow) was opacified.
D. 6-month follow-up angiography revealed that location of indwelling catheter was not changed, and hepatic artery (arrow) was patent.
CD122 patients demonstrated patent hepatic arterial flow
with no complication. For the remaining 16 patients,
complications related to the port-catheter system were
observed. Wound infection cases (n = 3) were detected by
a physician during a routine physical examinations. Port-
catheter system correction was attempted in 18 of 19
patients. In one case, local infection was controlled by
medical treatment and did not require correction of the
port-catheter system. Correction was possible and
chemotherapy was continued in 15 of 18 patients (83%).
Among the complications, catheter tip dislocation occurred
in seven patients; in five of the seven cases, successful
correction was performed, but in the other two cases, the
correction failed. Detailed correction methods and results
are presented in Table 2. If the correction of the catheter
position was necessary, repositioning of the catheter was
first attempted using a hydrophilic guidewire. However, if
the catheter repositioning failed, then catheter exchange
was attempted. In three cases, correction of the port-
catheter system could not be accomplished because of
proximal segment obstruction of the proper hepatic artery
in one patient, celiac trunk stenosis in another patient, and
gastroduodenal artery obstruction in another patient. No
correlation between the difference of the distal catheter tip
location and the complication rate was observed. Acute
gastroduodenal mucosal lesions occurred in 11 patients
(9%) who underwent hepatic arterial infusion chemother-
apy using an indwelling catheter, which was confirmed by
endoscopy. All of these patients recovered with medical
treatment. No other complication associated with this
procedure was observed.
Combined radiation therapy was performed in 50 of the
122 patients (41%) with hepatic arterial infusion
chemotherapy for the treatment of hepatocellular
carcinoma.
During follow-up, 49 of 122 patients were referred for
removal of the port-catheter system due to a switch in
treatment method; from hepatic arterial infusion
chemotherapy to other methods (n = 47) and local
infection (n = 2). The removal was performed successfully
without complications in 48 of 49 patients. In one case, the
port-catheter system could not be removed: when the
operator tried to pull it out, the catheter did not move to
the outside. Celiac angiography revealed patent hepatic
arterial flow, but the indwelling catheter was fixed to the
adjacent celiac trunk. We considered that adhesion had
occurred between the indwelling catheter and the adjacent
celiac trunk wall, and it was left alone. The remaining 73
patients continued with hepatic arterial infusion
chemotherapy and were followed as outpatients, or were
scheduled for catheter removal.
DISCUSSION
Among the various interventional techniques to achieve
implantation of port-catheter systems (6-11, 16-22), the
fixed-catheter-tip method (6, 17-22) is advantageous
because it prevents catheter dislocation and hepatic artery
Choi et al.
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Table 2. Complications in 122 Patients after Percutaneous Hepatic Artery Port-Catheter Insertion
Complications  Patients (%) Catheter Diameter* Correction Methods and Results (n)
Total 19 (16%)
Catheter tip dislocation 07 (6%) 5-Fr (n = 4), 5.8-Fr (n = 3) Catheter reposition (3)
Catheter exchange (2)
Removal (2)**
Port-catheter obstruction
Catheter obstruction 03 (3%) 5-Fr (n = 2), 5.8-Fr (n = 1) Catheter reposition (2)
Catheter exchange (1)
Port-chamber obstruction 01 (1%) 5-Fr (n = 1) Removal and reinsertion (1)
Hepatic artery obstruction 01 (1%) 5.5-Fr (n = 1) Removal (1)***
Kinking of catheter in subcutaneous space 04 (3%) 5-Fr (n = 4) Catheter reposition (3)
Catheter exchange (1)
Wound site complication
Skin infection 01 (1%) 5-Fr (n = 1) Medication (1)
Skin necrosis 02 (2%) 5.8 Fr (n = 2) Removal and reinsertion (2)****
Note.─ * = Diameter of indwelling catheter. ** = Correction of port-catheter system could not be accomplished because gastroduodenal artery obstruction 
occurred in one patient and celiac stenosis in another. Port-catheter systems were removed and treatment method was switched. *** = Correction of port-
catheter system could not be accomplished because of hepatic artery obstruction. Port-catheter systems were removed and treatment method was
switched. **** = Reinsertion was performed via contralateral common femoral artery.obstruction (6, 18-22). A review of large published studies
describing percutaneous port-catheter system placement
for hepatic arterial infusion chemotherapy using the fixed-
catheter-tip method, revealed that the rate of indwelling
catheter dislocation was 2-8% (16, 18, 19, 21-25), and the
rate of hepatic artery obstruction was 3-20% (19, 21-25).
However, several important problems exist with this
method such as the difficulty in catheter removal (19), the
long procedure duration for catheter-tip fixation using
microcoils alone or with n-butyl cyanoacrylate, and the
migration of the coil or cast of n-butyl cyanoacrylate.
Yamagami et al. (19) described one case (1%) of migration
of the cast of n-butyl cyanoacrylate occurring during the
procedure, and three cases (3%) of removal failure.
Another report described the withdrawal method of the
port-catheter system implanted using the fixed-catheter-tip
method (26). According to that report, 14 cases of catheter
withdrawal were performed because of catheter disloca-
tion (n = 6), infection (n = 3), brain infarction (n = 2),
catheter obstruction (n = 2), and hepatic artery obstruction
(n = 1). In that report, 14 of 15 cases of port-catheter
system removal were successful. However, meticulous care
and special devices were used to avoid dislocation of the
microcoils or n-butyl cyanoacrylate mixture that had been
used to fix the catheter tip into the hepatic arteries or
aorta: the leading edge of the indwelling catheter was
slowly moved while being carefully observed under real-
time fluoroscopy (26). Additionally, 10 of 15 patients
underwent reinsertion of the port-catheter system in that
study, but the new location of the distal catheter tip was
the splenic artery (n = 5) and a branch of the hepatic artery
(n = 5), but not the gastroduodenal artery. To resolve these
problems, Tajima et al. (27) developed a new catheter
system, termed the self-retaining indwelling catheter
system. This method was feasible and safe, but required a
special device.
A clinical trial using the simplified technique for the
implantable port-catheter system without tip-fixation
materials, such as coils, was previously performed (28).
However, the total number of patients was small (n = 43),
and a detailed evaluation of the catheter patency and
complication rate was required. 
In this study, we performed a detailed evaluation of a
simplified fixed-catheter-tip method that did not require
additional special devices. We chose the right or left
common femoral artery as the access route for implanta-
tion of the port-catheter system following angiography. We
used a non-tapered indwelling catheter, such as a 5-Fr or
5.8-Fr polyurethane catheter, where a tip-fixation effect
may be expected, and no coil insertion or n-butyl
cyanoacrylate embolization was performed for additional
catheter-tip fixation. In our study, catheter dislocation
occurred more frequently than in previous reports using
the classic fixed-catheter-tip method (18, 19, 21-25).
However, among 18 of the 19 cases with complications
that required correction of the implantable port-catheter
system, correction was possible in the majority of cases
with the distal catheter tip at the gastroepiploic or gastro-
duodenal artery. 
Seki et al. (12) reported that hepatic artery patency was
significantly higher in patients with port-catheter systems
implanted with the fixed-catheter-tip method using
microcoils alone or with n-butyl cyanoacrylate, than in
patients in whom the catheter tip had been placed in the
proper or common hepatic artery without fixation.
Additionally, the catheter tip location was different
between the two groups: gastroduodenal artery in the
former and proper or common hepatic artery in the latter,
and this difference could result in a bias. Hepatic arterial
occlusion resulted in mechanical stimulation to the vascular
wall by the catheter tip (16). Thus, the important factor in
hepatic arterial occlusion is not distal catheter tip fixation,
but the distal catheter tip location. In our study, the hepatic
artery obstruction rate was 1% without the fixed-catheter-
tip method, and this was a very low rate compared with
previous studies using the fixed-catheter-tip method (16,
19, 22, 27, 28). Thus, we conclude that distal catheter tip
fixation did not correlate with the hepatic arterial obstruc-
tion rate. Additionally, our very low hepatic arterial
obstruction rate was at least in part due to the relatively
few chemotherapy sessions. Our result indicated that the
mean number of arterial infusion chemotherapy sessions
with the portcatheter system was 3.9 ± 2.4 (mean ± SD),
and may consequently affect the patency of the hepatic
artery.
Catheter dislocation is a frustrating problem associated
with our method, but its occurrence was compensated for
by the ability to correct the problem. Additionally, hepatic
arterial occlusion was prevented by placing the indwelling
catheter tip in the gastroduodenal artery with no additional
fixation devices such as a coil or n-butyl cyanoacrylate.
Difficulty in removal is one important problem of the
conventional fixed-catheter-tip method. In our study,
removal failure occurred in only one case, and the duration
of catheterization in this case was 722 days. In the present
study, we did not measure the precise procedure duration,
but, according to our method, catheter-tip fixation is not
necessary and it will reduce the procedure duration
compared with the conventional fixed-catheter-tip method.
The incidence of acute gastroduodenal mucosal lesions in
our study was 9%, which was higher than reported for the
conventional fixed-catheter-tip method, at 2-6% (15, 16,
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influx of anticancer agents into the arteries originating
from the hepatic arteries and supplying the gastroduodenal
region. However, about 40% of our patients underwent
combined computer-controlled radiation therapy during
chemotherapy, and all of the patients with acute gastro-
duodenal mucosal lesions underwent this therapy. Thus,
this radiation therapy could have contributed to the high
incidence of gastroduodenal mucosal lesions.
Taken together, in our study, catheter tip dislocation
occurred slightly more frequently, but within an acceptable
range, compared with the conventional fixed-catheter-tip
method. Additionally, the occurrence of hepatic arterial
occlusion was low, difficulty in removal was rare, and our
method may reduce the procedure duration and medical
expenses. In conclusion, this simplified method
demonstrates excellent technical feasibility and an accept-
able range of problems. Furthermore, we recommend it for
the management of patients with advanced hepatocellular
carcinoma with portal vein thrombosis.
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